Expert Radar
Dr. Bert O'Neil, MD
Dr. Bert O'Neil, MD
Physician and Medical Director, Community Health Network
Doctor of Medicine, David Geffen School of Medicine at UCLA
Dr. Bert H. O'Neil has 23 years of experience in the fields of Medical Oncology and Hematology. He earned his BS in Biological Sciences from the University of California, Irvine and his MD from David Geffen School of Medicine at UCLA. After completing his residency in Medicine, he went on to complete his fellowship in Hematology and Oncology at the UCSF School of Medicine. Today, this expert is board-certified in Medical Oncology. Formerly, this expert served as the Joseph W. and Jackie J. Cusick Professor of Oncology at the Indiana University School of Medicine, as the Chief Scientific Officer of Hoosier Cancer Research Network, and as the Executive Medical Director of Early Phase Oncology at Eli Lilly and Company. He is currently the Medical Director of Oncology Research for Community Health Network.
b********@e*****.com
(317) ***-****
Indianapolis, Indiana
Get a FREE Demo of Dr. Bert O'Neil, MD's Radar Profile
Review this expert's litigation history, supporting legal docs, publications, professional background, and more.
Comprehensive data on expert witnesses: Access detailed litigation history and performance metrics.
Swift assessment: Quickly evaluate an expert's track record.
Informed decisions: Make better choices when selecting or challenging expert witnesses in any case.
Radar Metrics At A Glance
Expert Witness Activity
Plaintiff Cases
Defense Cases
Expert Challenges
Deposition Transcripts
Publications
171
Media & News
161
Social Media Mentions
13
Expert Institute operates independently and objectively as an expert witness data provider. Expert Institute does not employ, endorse, or have an affiliation with any expert witnesses for which data is provided.
Expert Witness Activity
Case Name | Role | Filed Date |
|---|
Unlock Dr. Bert O'Neil, MD's full profile
Litigation Analytics
Retained By
Defense
Plaintiff
Activity over time
0
25
50
75
100
2000
0
2002
0
2004
0
2006
0
2008
0
2010
0
Activity by state
Case Outcome
0
25
50
75
100
Publications
Radar found 171 records
Title | Type |
|---|---|
Detection of shared MHC-restricted human melanoma antigens after vaccinia virus-mediated transduction of genes coding for HLA | Journal Article |
Chapter 79: Cancer Colorectal | Book Chapter |
Chapter 82: Cancers du Tractus Gastro-Intestinal Supérieur | Book Chapter |
Radar monitors a wide array of publication sources, including links to abstracts.
Review book chapters, journal articles, research papers, trade publications, technical reports, conference proceedings, and more.
Media & News
Radar found 161 records
Title | Description |
|---|---|
Cancer Clinics of Excellence (CCE) Announces ... | Jun 12, 2024 ----- In addition, Linda Bosserman, MD ,Wilshire Oncology Medical Group was named Chief Medical Officer. ... Bert O'Neil , MD , University of North ... |
A Clinical Trial of Pembrolizumab (MK-3475) Evaluating ... | May 15, 2024 ----- ... Tumors ( KEYNOTE 158). B. Bert O'Neil , MD . Primary Investigator. J. Jessica MacLean. Primary Investigator. Not Recruiting. 18-100 years. All. |
Association of Diet Quality with Survival among People ... | by EL Van Blarigan 2020 Cited by 10 ----- ... O'Neil , Bert H.; Shaw, James E.; Polite, Blase N.; Hochster, Howard S.; Atkins, James N.; Goldberg, Richard M.; Mayer, Robert J.; Blanke ... |
Radar scours thousands of media and news sources across the internet 24/7.
Access interviews, webinars, TV appearances, blog posts, columns, whitepapers, PDFs, profressional profiles, and more.
Education
Institution | Degree Type |
|---|---|
David Geffen School of Medicine at UCLA | Doctor of Medicine |
University of California, Irvine | Bachelor of Science |
Work History
Title | Employer |
|---|---|
Physician and Medical Director | Community Health Network |
Director | Community MD Anderson Cancer Center - North |
Executive Medical Director | Eli Lilly and Company |
What to expect from a Radar profile
Access detailed litigation history and performance metrics.
Access your Radar profile through Expert iQ, our secure, cloud-based platform that hosts AI-driven insights.
Delivered in 3–5 business days
Receive your profile swiftly, with Radar gathering intelligence from thousands of data points.
24/7 monitoring for 12 months
Stay informed with continuous monitoring and live alerts, ensuring your profile is always up-to-date.
